$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-K Financial Statement

#000101473914000003 Filed on March 03, 2014

Income Statement

Concept	2013 Q4	2013	2012 Q4
Revenue	$225.5M	$696.5M	$180.7M
YoY Change	24.76%	17.36%	14.2%
Cost Of Revenue	$157.3M	$489.8M	$80.20M
YoY Change	96.13%	23.21%	-19.56%
Gross Profit	$68.20M	$206.7M	$60.39M
YoY Change	12.92%	5.49%	3.06%
Gross Profit Margin	30.24%	29.67%	33.41%
Selling, General & Admin	$69.30M	$67.40M	$30.00M
YoY Change	131.0%	-61.73%	-34.78%
% of Gross Profit	101.62%	32.62%	49.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.900M	$20.23M	$1.200M
YoY Change	58.33%	141.74%	33.33%
% of Gross Profit	2.79%	9.79%	1.99%
Operating Expenses	$65.80M	$209.1M	$31.10M
YoY Change	111.58%	16.1%	-33.69%
Operating Profit	$2.396M	-$26.25M	$29.29M
YoY Change	-91.82%	-493.21%	150.41%
Interest Expense	-$8.000M	$28.20M	-$6.400M
YoY Change	25.0%	8.17%	3.23%
% of Operating Profit	-333.89%		-21.85%
Other Income/Expense, Net
YoY Change
Pretax Income	-$13.01M	-$70.38M	-$9.800M
YoY Change	32.77%	262.94%	-281.48%
Income Tax	$2.600M	$1.260M	-$4.500M
% Of Pretax Income
Net Earnings	-$18.56M	-$69.65M	$7.180M
YoY Change	-358.48%	-207.65%	7.02%
Net Earnings / Revenue	-8.23%	-10.0%	3.97%
Basic Earnings Per Share	-$0.27	-$1.08	$0.12
Diluted Earnings Per Share	-$1.094M	-$4.329M	$0.12
COMMON SHARES
Basic Shares Outstanding	68.11M shares	64.56M shares	56.89M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q4	2013	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.000M	$1.000M	$62.10M
YoY Change	-98.39%	-98.39%
Cash & Equivalents	$1.001M	$1.000M	$62.10M
Short-Term Investments
Other Short-Term Assets	$29.40M	$29.40M	$10.20M
YoY Change	188.24%	188.24%	-79.23%
Inventory	$34.34M	$34.30M	$34.03M
Prepaid Expenses
Receivables	$172.2M	$172.2M	$129.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$237.0M	$237.0M	$235.4M
YoY Change	0.65%	0.68%	-19.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$41.18M	$41.20M	$23.72M
YoY Change	73.61%	73.84%	-11.98%
Goodwill	$571.3M		$317.0M
YoY Change	80.22%		1.49%
Intangibles	$16.82M		$17.45M
YoY Change	-3.57%		-11.09%
Long-Term Investments	$0.00		$10.04M
YoY Change	-100.0%
Other Assets	$3.733M	$70.60M	$2.053M
YoY Change	81.83%	1340.82%	32.28%
Total Long-Term Assets	$699.9M	$699.9M	$406.9M
YoY Change	71.99%	71.97%	5.8%
TOTAL ASSETS
Total Short-Term Assets	$237.0M	$237.0M	$235.4M
Total Long-Term Assets	$699.9M	$699.9M	$406.9M
Total Assets	$936.9M	$936.9M	$642.4M
YoY Change	45.84%	45.84%	-5.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$63.58M	$63.60M	$34.44M
YoY Change	84.61%	84.88%	-56.49%
Accrued Expenses	$38.50M	$38.50M	$47.30M
YoY Change	-18.6%	-18.6%	22.86%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$60.26M	$60.30M	$953.0K
YoY Change	6222.88%	5930.0%	-98.56%
Total Short-Term Liabilities	$176.3M	$176.3M	$108.3M
YoY Change	62.86%	62.79%	-50.96%
LONG-TERM LIABILITIES
Long-Term Debt	$375.3M	$375.3M	$225.4M
YoY Change	66.49%	66.5%	-0.82%
Other Long-Term Liabilities	$17.54M	$23.70M	$4.981M
YoY Change	252.14%	374.0%	44.13%
Total Long-Term Liabilities	$392.9M	$399.0M	$230.4M
YoY Change	70.51%	73.18%	-0.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$176.3M	$176.3M	$108.3M
Total Long-Term Liabilities	$392.9M	$399.0M	$230.4M
Total Liabilities	$582.3M	$582.3M	$349.0M
YoY Change	66.86%	66.85%	-24.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$154.7M		-$85.08M
YoY Change	81.86%		-43.2%
Common Stock	$519.6M		$388.8M
YoY Change	33.65%		3.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.31M		$10.31M
YoY Change	0.0%		-1.43%
Treasury Stock Shares	2.583M shares		2.583M shares
Shareholders Equity	$354.6M	$354.6M	$293.4M
YoY Change
Total Liabilities & Shareholders Equity	$936.9M	$936.9M	$642.4M
YoY Change	45.84%	45.84%	-5.13%

Cashflow Statement

Concept	2013 Q4	2013	2012 Q4
OPERATING ACTIVITIES
Net Income	-$18.56M	-$69.65M	$7.180M
YoY Change	-358.48%	-207.65%	7.02%
Depreciation, Depletion And Amortization	$1.900M	$20.23M	$1.200M
YoY Change	58.33%	141.74%	33.33%
Cash From Operating Activities	-$16.30M	-$54.58M	$1.600M
YoY Change	-1118.75%	-303.02%	-112.9%
INVESTING ACTIVITIES
Capital Expenditures	-$5.600M	-$25.60M	-$5.200M
YoY Change	7.69%	132.73%	40.54%
Acquisitions		$283.0M
YoY Change		557.43%
Other Investing Activities	$2.100M	-$276.7M	-$4.100M
YoY Change	-151.22%	-363.78%	-920.0%
Cash From Investing Activities	-$3.600M	-$302.3M	-$9.300M
YoY Change	-61.29%	-422.05%	200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$118.4M
YoY Change
Debt Paid & Issued, Net		$5.000M
YoY Change
Cash From Financing Activities	20.80M	$295.8M	2.600M
YoY Change	700.0%	-604.28%	-83.23%
NET CHANGE
Cash From Operating Activities	-16.30M	-$54.58M	1.600M
Cash From Investing Activities	-3.600M	-$302.3M	-9.300M
Cash From Financing Activities	20.80M	$295.8M	2.600M
Net Change In Cash	900.0K	-$61.10M	-5.100M
YoY Change	-117.65%	-198.39%	-54760833024000140.0%
FREE CASH FLOW
Cash From Operating Activities	-$16.30M	-$54.58M	$1.600M
Capital Expenditures	-$5.600M	-$25.60M	-$5.200M
Free Cash Flow	-$10.70M	-$28.98M	$6.800M
YoY Change	-257.35%	-176.5%	-178.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	64342000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	34438000	USD
CY2013Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	206514000	USD
CY2012Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	151315000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	187301000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	129103000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42630000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33365000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	519625000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	388798000	USD
CY2012	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3957000	USD
CY2011	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3376000	USD
CY2013	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6671000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4297000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4986000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9498000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	-19213000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	-22212000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	22212000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	19213000	USD
CY2011	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1055000	USD
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2259000	USD
CY2012	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1261000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6671000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3957000	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3376000	USD
CY2012Q4	us-gaap	Assets Assets	642376000	USD
CY2013Q4	us-gaap	Assets Assets	936858000	USD
CY2011Q4	us-gaap	Assets Assets	677102000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	236956000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	235427000	USD
CY2012Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	46708000	USD
CY2012Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	30859000	USD
CY2011	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2013	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	16130000	USD
CY2012	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4046000	USD
CY2012Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2900000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	1012000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	333000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	1000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	39000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	201000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	438000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2013	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	1724000	USD
CY2011	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	800000	USD
CY2012	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	1325000	USD
CY2012Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	9939000	USD
CY2013Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	13842000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1001000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62101000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-61100000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	0	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	62101000	USD
CY2013	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2011	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-1591000	USD
CY2012	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	161499000	USD
CY2012	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-22978000	USD
CY2011	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	23905000	USD
CY2013	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-16048000	USD
CY2013Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	10.00
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3100000	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70711439	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59600713	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68128919	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57026957	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	7000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2012Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	4315000	USD
CY2013Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	8820000	USD
CY2012	us-gaap	Cost Of Revenue CostOfRevenue	437677000	USD
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	570381000	USD
CY2011	us-gaap	Cost Of Revenue CostOfRevenue	339091000	USD
CY2012	us-gaap	Cost Of Services CostOfServices	112406000	USD
CY2013	us-gaap	Cost Of Services CostOfServices	104226000	USD
CY2011	us-gaap	Cost Of Services CostOfServices	101019000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-3759000	USD
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-167000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-866000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-2278000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-4435000	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-289000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-1412000	USD
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-122000	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-676000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4437000	USD
CY2011	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	632000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	121000	USD
CY2013Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	21900000	USD
CY2012Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2877000	USD
CY2013Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	17184000	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	724000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4816000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	379000	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-125000	USD
CY2011	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	92000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	7278000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	8089000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43886000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	64802000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16287000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39556000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	417000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1778000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3717000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6277000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	3055000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	148000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	11771000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	10315000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	63281000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39727000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	15107000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	10291000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	16122000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	11306000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	15107000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	10291000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3144000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	506000	USD
CY2013	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	500000	USD
CY2013	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2013Q2	us-gaap	Deposit Assets DepositAssets	1000000	USD
CY2012	us-gaap	Depreciation Depreciation	8513000	USD
CY2011	us-gaap	Depreciation Depreciation	6591000	USD
CY2013	us-gaap	Depreciation Depreciation	13555000	USD
CY2013Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	-6400000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	79200000	USD
CY2012Q2	us-gaap	Disposal Group Including Discontinued Operation Goodwill DisposalGroupIncludingDiscontinuedOperationGoodwill	11754000	USD
CY2012Q2	us-gaap	Disposal Group Including Discontinued Operation Intangible Assets Net DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNet	2503000	USD
CY2012Q2	us-gaap	Disposal Group Including Discontinued Operation Inventory DisposalGroupIncludingDiscontinuedOperationInventory	30560000	USD
CY2012Q2	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Net DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet	1592000	USD
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.28
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2012	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	8611000	USD
CY2011	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	3198000	USD
CY2013	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	2549000	USD
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	13100000	USD
CY2012Q4	us-gaap	Equity Method Investments EquityMethodInvestments	10042000	USD
CY2013Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9854000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16526000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	59000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5571000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1221000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2385000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2622000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4966000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33350000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11900000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2046000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16824000	USD
CY2012Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	3219000	USD
CY2013Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	4461000	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-156000	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-201000	USD
CY2011	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-15898000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	605121000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	350810000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	312387000	USD
CY2012	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	38423000	USD
CY2013	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	254304000	USD
CY2013	us-gaap	Goodwill Other Changes GoodwillOtherChanges	7000	USD
CY2013	us-gaap	Gross Profit GrossProfit	271814000	USD
CY2011	us-gaap	Gross Profit GrossProfit	215415000	USD
CY2012	us-gaap	Gross Profit GrossProfit	224960000	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	58004000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	68682000	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	60393000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	53041000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	63237000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	74883000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	53522000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	65012000	USD
CY2011	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	238072000	USD
CY2013	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	466155000	USD
CY2012	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	325271000	USD
CY2013	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	675684000	USD
CY2011	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	365526000	USD
CY2012	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	471506000	USD
CY2013	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	166511000	USD
CY2012	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	191131000	USD
CY2011	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	188980000	USD
CY2013	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	842195000	USD
CY2011	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	554506000	USD
CY2012	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	662637000	USD
CY2013Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	243512000	USD
CY2013Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	208879000	USD
CY2012Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	170365000	USD
CY2013Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	190733000	USD
CY2012Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	155901000	USD
CY2012Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	180738000	USD
CY2012Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	155633000	USD
CY2013Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	199071000	USD
CY2012	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	5800000	USD
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8340000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-53606000	USD
CY2011	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-424000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-605000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-22442000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7470000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4293000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8317000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-15377000	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1419000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2023000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-51068000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12779000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2011	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.83
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2012Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.04
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.35
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.22
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	76059000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-563000	USD
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	8599000	USD
CY2012Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-680000	USD
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3182000	USD
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-11645000	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1104000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-17874000	USD
CY2011	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4000	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4473000	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	0	USD
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	0	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	317000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2011	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	214000	USD
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-10931000	USD
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-658000	USD
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8296000	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-16048000	USD
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	73047000	USD
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.15
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.25
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	1.30
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2012Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.18
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.05
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	1.35
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.15
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.19
CY2012	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-675000	USD
CY2011	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	435000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2538000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4439000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	23493000	USD
CY2011	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	778000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	150000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	178000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2419000	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-587000	USD
CY2011	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	36000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-633000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-1157000	USD
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3137000	USD
CY2011	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1042000	USD
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	242000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1659000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-48200000	USD
CY2011	us-gaap	Interest Expense Other InterestExpenseOther	-183000	USD
CY2013	us-gaap	Interest Expense Other InterestExpenseOther	-15000	USD
CY2011	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	25542000	USD
CY2012	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	26067000	USD
CY2013	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	28197000	USD
CY2011	us-gaap	Interest Paid Net InterestPaidNet	27528000	USD
CY2013	us-gaap	Interest Paid Net InterestPaidNet	22598000	USD
CY2012	us-gaap	Interest Paid Net InterestPaidNet	25589000	USD
CY2011	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-675000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	22136000	USD
CY2013	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-3627000	USD
CY2012	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-22000	USD
CY2011	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	59000	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2497000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4939000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15249000	USD
CY2013	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-5656000	USD
CY2011	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-2945000	USD
CY2012	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	8112000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3726000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	420000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-11211000	USD
CY2012	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-101230000	USD
CY2011	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	31690000	USD
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	31861000	USD
CY2012Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	15400000	USD
CY2013Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	15400000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17446000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	32224000	USD
CY2012	us-gaap	Interest Expense InterestExpense	26067000	USD
CY2013	us-gaap	Interest Expense InterestExpense	28197000	USD
CY2011	us-gaap	Interest Expense InterestExpense	25542000	USD
CY2012	us-gaap	Interest Expense Other InterestExpenseOther	-171000	USD
CY2012Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	5803000	USD
CY2013Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2173000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	34341000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	34034000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7900000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	6200000	USD
CY2011	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	6300000	USD
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	7164000	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	12232000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	582275000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	348967000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	642376000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	936858000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	108269000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	174306000	USD
CY2013Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	16300000	USD
CY2013Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	4300000	USD
CY2013Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	12000000	USD
CY2012	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0469
CY2013	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0543
CY2013	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.005
CY2012	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	800000	USD
CY2011	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	4800000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	536919000	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	375323000	USD
CY2012Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	225426000	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	60257000	USD
CY2012Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	953000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	60257000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	953000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	323979000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	45188000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	39988000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	41288000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	42588000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	43888000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	375322000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	225426000	USD
CY2013	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	37300000	USD
CY2013	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	3500000.0	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17062000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	295823000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-58663000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9907000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-302370000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	93880000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-302370000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-67619000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-8316000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26969000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54553000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26884000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3064000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-38505000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	49862000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	64707000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	7872000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-69654000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-34087000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-18559000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	71766000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-8880000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	7180000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-8128000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-11536000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-2703000	USD
CY2013	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	9622000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	3242000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5038000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	6202000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7771000	USD
CY2013	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	13288000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-6973000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	25553000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	35052000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	3177000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3761000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2053000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17540000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4981000	USD
CY2013	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	4816000	USD
CY2011	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	1153000	USD
CY2012	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	-4000	USD
CY2013	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	233038000	USD
CY2012	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	184491000	USD
CY2011	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	167136000	USD
CY2013	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	2363000	USD
CY2012	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	0	USD
CY2011	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	0	USD
CY2013Q2	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-8600000	USD
CY2013	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	25626000	USD
CY2011	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	7853000	USD
CY2012	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	10986000	USD
CY2011	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	22000	USD
CY2011	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	189000	USD
CY2012	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	174000	USD
CY2011	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2013	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2012	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	10652000	USD
CY2013	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	282998000	USD
CY2012	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	43046000	USD
CY2011	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	463000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2012	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1244050000	USD
CY2013	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	449559000	USD
CY2011	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1773644000	USD
CY2012Q1	us-gaap	Proceeds From Collaborators ProceedsFromCollaborators	3000000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	118382000	USD
CY2012	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2011	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2013	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	378091000	USD
CY2012	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2013	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	8617000	USD
CY2011	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2011	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8611000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3198000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2549000	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	399000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57086000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	84242000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23721000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41612000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	20963000	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	14035000	USD
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11441000	USD
CY2012	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1307872000	USD
CY2011	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1791058000	USD
CY2013	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	409559000	USD
CY2013Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	21000000	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	802000	USD
CY2012	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3278000	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2635000	USD
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5000000	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2012	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2013	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	237397000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	100000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	300000	USD
CY2011	us-gaap	Restructuring And Related Cost Expected Cost RestructuringAndRelatedCostExpectedCost	-7909000	USD
CY2013	us-gaap	Restructuring And Related Cost Expected Cost RestructuringAndRelatedCostExpectedCost	-9796000	USD
CY2012	us-gaap	Restructuring And Related Cost Expected Cost RestructuringAndRelatedCostExpectedCost	-5143000	USD
CY2012	us-gaap	Restructuring Charges RestructuringCharges	5143000	USD
CY2013	us-gaap	Restructuring Charges RestructuringCharges	7771000	USD
CY2011	us-gaap	Restructuring Charges RestructuringCharges	7909000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-154738000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85084000	USD
CY2013	us-gaap	Revenue Recognition Discounts RevenueRecognitionDiscounts	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Allowance for Contractual Discounts</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is reimbursed by payors for products and services the Company provides. Payments for medications and services covered by payors are generally less than billed charges.  The Company monitors revenue and receivables from payors on an account-specific basis and records an estimated contractual allowance for certain revenue and receivable balances at the revenue recognition date to properly account for anticipated differences between amounts billed and amounts reimbursed.  Accordingly, the total revenue and receivables reported in our financial statements are recorded at the amounts expected to be received from these payors.   For the significant portion of the Company's revenue, the contractual allowance is estimated based on several criteria, including unbilled claims, historical trends based on actual claims paid, current contract and reimbursement terms and changes in customer base and payor/product mix. Contractual allowance estimates are adjusted to actual amounts as cash is received and claims are settled. We do not believe these changes in estimates are material. The billing functions for the remaining portion of the Company's revenue are largely computerized, which enables on-line adjudication (i.e., submitting charges to third-party payors electronically with simultaneous feedback of the amount the primary insurance plan expects to pay) at the time of sale to record net revenue, exposure to estimating contractual allowance adjustments is limited on this portion of the business.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2013	us-gaap	Revenue Recognition Rebates RevenueRecognitionRebates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rebates</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturers’ rebates are part of each of the Company’s segments.  Rebates are generally volume-based incentives that are earned and recorded upon purchase of the inventory.  Rebates are recorded as a reduction of both inventory and cost of goods sold.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PBM rebates are recorded on historical PBM results and trends and are revised on a regular basis depending on the Company’s latest forecasts, as well as information received from rebate sources.  Should actual results differ, adjustments will be recorded in future earnings when the adjustment becomes known.  In some instances, rebate payments are shared with the Company’s Plan Sponsors.  PBM rebates earned by the Company are recorded as a reduction of cost of goods sold.  PBM rebates shared with clients are recorded as a reduction of revenue consistent with the sales incentive provisions of ASC 605.</font></div></div>
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	215279000	USD
CY2012Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	7411000	USD
CY2013Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	2547000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1582000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	430000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	487000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	200000	USD
CY2010Q1	bios	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	3400000	shares
CY2013	bios	Class Of Warrant Or Right Term ClassOfWarrantOrRightTerm	P5Y
CY2013	bios	Classof Warrantor Right Fair Value Assumptions Expected Dividend Rate ClassofWarrantorRightFairValueAssumptionsExpectedDividendRate	0
CY2013Q4	bios	Computer And Office Equipment Gross ComputerAndOfficeEquipmentGross	20440000	USD
CY2011	bios	Income Tax Reconciliation Tax Penalties Domestic IncomeTaxReconciliationTaxPenaltiesDomestic	78000	USD
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2582520	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2582520	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10311000	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10311000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1172000	USD
CY2010Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2869000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2605000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2754000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	212000	USD
CY2012	bios	Income Tax Reconciliation Tax Penalties Domestic IncomeTaxReconciliationTaxPenaltiesDomestic	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	378000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	636000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	6122000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	9450000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	4467000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4400000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3800000	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2500000	USD
CY2013Q4	bios	Future Minimum Payments Due FutureMinimumPaymentsDue	36064000	USD
CY2013Q4	bios	Future Minimum Payments Due Current FutureMinimumPaymentsDueCurrent	9955000	USD
CY2013Q4	bios	Future Minimum Payments Due In Five Years FutureMinimumPaymentsDueInFiveYears	3243000	USD
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2492009	shares
CY2012Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1900000	shares
CY2011Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	3300000	shares
CY2013Q2	us-gaap	Share Price SharePrice	12
CY2013	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y8M26D
CY2012	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	25999	shares
CY2011	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	25273	shares
CY2013	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	0	shares
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	10406250	shares
CY2013Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	118400000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	293409000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	354583000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	200101000	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64560000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56239000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54505000	shares
CY2012Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	41491000	USD
CY2013Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	39897000	USD
CY2011	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	0	USD
CY2013	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	16130000	USD
CY2012	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	4046000	USD
CY2012	bios	Adjusted Ebitda AdjustedEbitda	67824000	USD
CY2011	bios	Adjusted Ebitda AdjustedEbitda	71204000	USD
CY2013	bios	Adjusted Ebitda AdjustedEbitda	80671000	USD
CY2012Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	18173000	USD
CY2013Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	5090000	USD
CY2013Q4	bios	Future Minimum Payments Due In Four Years FutureMinimumPaymentsDueInFourYears	5077000	USD
CY2013Q4	bios	Future Minimum Payments Due In Three Years FutureMinimumPaymentsDueInThreeYears	6403000	USD
CY2013Q4	bios	Future Minimum Payments Due In Two Years FutureMinimumPaymentsDueInTwoYears	8209000	USD
CY2013	bios	Income Tax Reconciliation Tax Penalties Domestic IncomeTaxReconciliationTaxPenaltiesDomestic	0	USD
CY2013	bios	Availablesharesreducedperrestrictedstockshareissued Availablesharesreducedperrestrictedstockshareissued	1.53
CY2013	bios	Businesscombinationacquisitionrelatedcostschangeincontingentconsideration Businesscombinationacquisitionrelatedcostschangeincontingentconsideration	-5786000	USD
CY2011	bios	Businesscombinationacquisitionrelatedcostschangeincontingentconsideration Businesscombinationacquisitionrelatedcostschangeincontingentconsideration	0	USD
CY2012	bios	Businesscombinationacquisitionrelatedcostschangeincontingentconsideration Businesscombinationacquisitionrelatedcostschangeincontingentconsideration	0	USD
CY2012	bios	Businesscombinationcontingentconsiderationperiod Businesscombinationcontingentconsiderationperiod	P24M
CY2013	bios	Capital Expenditures CapitalExpenditures	25617000	USD
CY2011	bios	Capital Expenditures CapitalExpenditures	7853000	USD
CY2012	bios	Capital Expenditures CapitalExpenditures	10986000	USD
CY2013	bios	Capital Lease Obligations Incurred To Acquire Property And Equipment CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment	145000	USD
CY2012	bios	Capital Lease Obligations Incurred To Acquire Property And Equipment CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment	20000	USD
CY2011	bios	Capital Lease Obligations Incurred To Acquire Property And Equipment CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment	6631000	USD
CY2013	bios	Cash Consideration Paid To Ds Pharmacy CashConsiderationPaidToDsPharmacy	0	USD
CY2012	bios	Cash Consideration Paid To Ds Pharmacy CashConsiderationPaidToDsPharmacy	2935000	USD
CY2011	bios	Cash Consideration Paid To Ds Pharmacy CashConsiderationPaidToDsPharmacy	0	USD
CY2013	bios	Cash Equivalents Maturity Term Maximum CashEquivalentsMaturityTermMaximum	P3M
CY2013	bios	Class Of Warrant Or Right Fair Value Assumptions Discount For Postvesting Restrictions ClassOfWarrantOrRightFairValueAssumptionsDiscountForPostvestingRestrictions	0.135
CY2013	bios	Class Of Warrant Or Right Fair Value Assumptions Expected Term ClassOfWarrantOrRightFairValueAssumptionsExpectedTerm	P5Y
CY2013	bios	Class Of Warrant Or Right Fair Value Assumptions Expected Volatility Rate ClassOfWarrantOrRightFairValueAssumptionsExpectedVolatilityRate	0.62
CY2013	bios	Class Of Warrant Or Right Fair Value Assumptions Risk Free Interest Rate ClassOfWarrantOrRightFairValueAssumptionsRiskFreeInterestRate	0.0263
CY2013Q4	bios	Class Of Warrant Or Right Fair Value Of Warrants Outstanding ClassOfWarrantOrRightFairValueOfWarrantsOutstanding	12300000	USD
CY2012Q4	bios	Computer And Office Equipment Gross ComputerAndOfficeEquipmentGross	14443000	USD
	bios	Discontinued Operation Transaction Costs From Disposal Of Discontinued Operation DiscontinuedOperationTransactionCostsFromDisposalOfDiscontinuedOperation	5600000	USD
CY2012	bios	Discontinued Operations Costs Included In Net Gain From Disposal Of Discontinued Operation DiscontinuedOperationsCostsIncludedInNetGainFromDisposalOfDiscontinuedOperation	13387000	USD
CY2013	bios	Discontinued Operations Costs Included In Net Gain From Disposalof Discontinued Operation Excluding Legal Settlement DiscontinuedOperationsCostsIncludedInNetGainFromDisposalofDiscontinuedOperationExcludingLegalSettlement	7600000	USD
	bios	Discontinued Operations Deferred Tax Assets Included In Effective Tax Calculation DiscontinuedOperationsDeferredTaxAssetsIncludedInEffectiveTaxCalculation	24100000	USD
	bios	Discontinued Operations Gain On Disposal Before Costs Resulting From Disposal DiscontinuedOperationsGainOnDisposalBeforeCostsResultingFromDisposal	108200000	USD
	bios	Discontinued Operations Gain On Disposal Netof Costs Resulting From Disposal DiscontinuedOperationsGainOnDisposalNetofCostsResultingFromDisposal	101600000	USD
CY2012Q2	bios	Disposal Group Including Discontinued Operation Proceeds DisposalGroupIncludingDiscontinuedOperationProceeds	173800000	USD
CY2012Q2	bios	Disposal Group Including Discontinued Operation Proceeds Subsequentto Closefor Retentionof Certain Business DisposalGroupIncludingDiscontinuedOperationProceedsSubsequenttoCloseforRetentionofCertainBusiness	15000000	USD
CY2012Q2	bios	Disposal Group Including Discontinued Operations Prepaid Expenses And Other Current Assets DisposalGroupIncludingDiscontinuedOperationsPrepaidExpensesAndOtherCurrentAssets	299000	USD
CY2012Q4	bios	Disposal Groups Including Discontinued Operations Remaining Net Assets DisposalGroupsIncludingDiscontinuedOperationsRemainingNetAssets	4800000	USD
CY2013Q4	bios	Disposal Groups Including Discontinued Operations Remaining Net Assets DisposalGroupsIncludingDiscontinuedOperationsRemainingNetAssets	0	USD
CY2012Q4	bios	Disposalgroupincludingdiscontinuedoperationsremainingallowancefordoubtfulaccounts Disposalgroupincludingdiscontinuedoperationsremainingallowancefordoubtfulaccounts	8045000	USD
CY2012Q4	bios	Disposalgroupincludingdiscontinuedoperationsremaininggrossreceivables Disposalgroupincludingdiscontinuedoperationsremaininggrossreceivables	12840000	USD
CY2013Q4	bios	Duefrom Saleof Affiliate Equity Investment Noncurrent DuefromSaleofAffiliateEquityInvestmentNoncurrent	2200000	USD
CY2013Q4	bios	Employee Stock Ownership Plan Sharestobe Registered EmployeeStockOwnershipPlanSharestobeRegistered	750000	shares
CY2013	bios	Future Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net FutureAdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	17900000	USD
CY2013Q4	bios	Future Minimum Leases Due Thereafter FutureMinimumLeasesDueThereafter	3177000	USD
CY2013	bios	Increase Decreasein Amountsduetoplansponsor IncreaseDecreaseinAmountsduetoplansponsor	-13084000	USD
CY2011	bios	Increase Decreasein Amountsduetoplansponsor IncreaseDecreaseinAmountsduetoplansponsor	5437000	USD
CY2012	bios	Increase Decreasein Amountsduetoplansponsor IncreaseDecreaseinAmountsduetoplansponsor	-7046000	USD
CY2011	bios	Increase Decreasein Claimspayable IncreaseDecreaseinClaimspayable	8729000	USD
CY2013	bios	Increase Decreasein Claimspayable IncreaseDecreaseinClaimspayable	-4864000	USD
CY2012	bios	Increase Decreasein Claimspayable IncreaseDecreaseinClaimspayable	-4354000	USD
CY2012Q4	bios	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	0	USD
CY2013Q4	bios	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	0	USD
CY2012Q4	bios	Indefinite Lived Intangible Assets Gross IndefiniteLivedIntangibleAssetsGross	15400000	USD
CY2013Q4	bios	Indefinite Lived Intangible Assets Gross IndefiniteLivedIntangibleAssetsGross	15400000	USD
CY2012Q2	bios	Initialportionofthesalepricereceivedincashatclosinginthe Pharmacy Services Asset Sale. InitialportionofthesalepricereceivedincashatclosinginthePharmacyServicesAssetSale.	158800000	USD
CY2013Q4	bios	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	16526000	USD
CY2012Q4	bios	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	9854000	USD
CY2012Q4	bios	Intangible Assets Gross IntangibleAssetsGross	27300000	USD
CY2013Q4	bios	Intangible Assets Gross IntangibleAssetsGross	48750000	USD
CY2013	bios	Interestratelegalsettlement Interestratelegalsettlement	0.0325
CY2013Q4	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	435580000	USD
CY2012Q4	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	226379000	USD
CY2013Q4	bios	Medical Equipment Gross MedicalEquipmentGross	22391000	USD
CY2012Q4	bios	Medical Equipment Gross MedicalEquipmentGross	16466000	USD
CY2013Q4	bios	Percent Of Accounts Receivable PercentOfAccountsReceivable	0.09
CY2013Q4	bios	Percent Of Pro Forma Accounts Receivable PercentOfProFormaAccountsReceivable	0.115
CY2012Q4	bios	Percent Of Pro Forma Accounts Receivable PercentOfProFormaAccountsReceivable	0.102
CY2013	bios	Percentageof Fair Valueof Common Stock Issuedthatwill Trigger Increasein Common Stock Issued Upon Exerciseof Warrants PercentageofFairValueofCommonStockIssuedthatwillTriggerIncreaseinCommonStockIssuedUponExerciseofWarrants	0.9
CY2012Q4	bios	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	10189000	USD
CY2013Q4	bios	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	14313000	USD
CY2012Q4	bios	Pro Forma Accounts Receivable ProFormaAccountsReceivable	138475000	USD
CY2013Q4	bios	Pro Forma Accounts Receivable ProFormaAccountsReceivable	211757000	USD
CY2012Q4	bios	Pro Forma Allowancefor Doubtful Accounts Relatedto Continuing Operations ProFormaAllowanceforDoubtfulAccountsRelatedtoContinuingOperations	-14167000	USD
CY2013Q4	bios	Pro Forma Allowancefor Doubtful Accounts Relatedto Continuing Operations ProFormaAllowanceforDoubtfulAccountsRelatedtoContinuingOperations	-24456000	USD
CY2013Q4	bios	Pro Forma Net Trade Receivables ProFormaNetTradeReceivables	187301000	USD
CY2012Q4	bios	Pro Forma Net Trade Receivables ProFormaNetTradeReceivables	124308000	USD
CY2013Q2	bios	Proceedsfrom Issuanceof Common Stock Used To Fund Acquisition ProceedsfromIssuanceofCommonStockUsedToFundAcquisition	61100000	USD
CY2013	bios	Revenuerecognitionperiod REVENUERECOGNITIONPERIOD	P60D
	bios	Saleof Affiliate Equity Investment Period After Close Expectedto Receive Additional Servicesor Cash SaleofAffiliateEquityInvestmentPeriodAfterCloseExpectedtoReceiveAdditionalServicesorCash	P2Y
CY2013Q2	dei	Entity Public Float EntityPublicFloat	776433834	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013Q2	bios	Stock Issued During Period Shares Selling Stockholders StockIssuedDuringPeriodSharesSellingStockholders	3968750	shares
CY2011	bios	Stock Issued During Period Value Treasury Stock Reissued Compensation StockIssuedDuringPeriodValueTreasuryStockReissuedCompensation	0	USD
CY2012	bios	Stock Issued During Period Value Treasury Stock Reissued Compensation StockIssuedDuringPeriodValueTreasuryStockReissuedCompensation	0	USD
CY2011	bios	Surrender Of Stock To Satisfy Minimum Tax Withholding SurrenderOfStockToSatisfyMinimumTaxWithholding	-189000	USD
CY2012	bios	Surrender Of Stock To Satisfy Minimum Tax Withholding SurrenderOfStockToSatisfyMinimumTaxWithholding	-174000	USD
CY2013	bios	Surrender Of Stock To Satisfy Minimum Tax Withholding SurrenderOfStockToSatisfyMinimumTaxWithholding	0	USD
CY2012	bios	Transitional Expense State Tax Related TransitionalExpenseStateTaxRelated	800000	USD
CY2013	bios	Transitional Expenses TransitionalExpenses	4400000	USD
CY2011	bios	Transitional Expenses TransitionalExpenses	1500000	USD
CY2012	bios	Transitional Expenses TransitionalExpenses	3000000	USD
CY2013Q4	bios	Variable Interest Entity Reporting Entity Involvement Initial Investment Amount VariableInterestEntityReportingEntityInvolvementInitialInvestmentAmount	6900000	USD
CY2013Q4	bios	Vehicles Gross VehiclesGross	2056000	USD
CY2012Q4	bios	Vehicles Gross VehiclesGross	1540000	USD
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	68187087	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer

Files In Submission

Name	View Source	Status
0001014739-14-000003-index-headers.html	Edgar Link	pending
0001014739-14-000003-index.html	Edgar Link	pending
0001014739-14-000003.txt	Edgar Link	pending
0001014739-14-000003-xbrl.zip	Edgar Link	pending
bios-20131231.xml	Edgar Link	completed
bios-20131231.xsd	Edgar Link	pending
bios-20131231x10k.htm	Edgar Link	pending
bios-20131231_cal.xml	Edgar Link	unprocessable
bios-20131231_def.xml	Edgar Link	unprocessable
bios-20131231_lab.xml	Edgar Link	unprocessable
bios-20131231_pre.xml	Edgar Link	unprocessable
bios-ex1024xx20131231x10k.htm	Edgar Link	pending
bios-ex1025xx20131231x10k.htm	Edgar Link	pending
bios-ex211xx20131231x10k.htm	Edgar Link	pending
bios-ex231xx20131231x10k.htm	Edgar Link	pending
bios-ex311xx20131231x10k.htm	Edgar Link	pending
bios-ex312xx20131231x10k.htm	Edgar Link	pending
bios-ex321xx20131231x10k.htm	Edgar Link	pending
bios-ex322xx201312x31x10k.htm	Edgar Link	pending
bioscriplogoa04.jpg	Edgar Link	pending
bioscummulativereturngraph.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2013 Q4 Form 10-K Financial Statement

#000101473914000003 Filed on March 03, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2013 Q4 Form 10-K Financial Statement

#000101473914000003 Filed on March 03, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch